Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Removing the ovarian tumor improved the woman's hormonal symptoms.

Women with PCOS have different hormone levels than those without it.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Sertoli-Leydig cell tumors are rare ovarian tumors that can cause symptoms like menorrhagia.

AMH and ovarian morphology help diagnose and understand PCOS more precisely.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Certain gene variations are found in people with polycystic ovary syndrome.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Examining many sections is key to correctly diagnosing hair follicle disorders.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Doppler ultrasonography can effectively detect blood flow changes in women with PCOS.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

The document's conclusion cannot be provided because the document is not accessible or understandable.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.